NEXAF
Several hundred participants with atrial fibrillation are being monitored using AQ and Mia Health to see how exercise affects their condition.
500 participants with atrial fibrillation
250 of them were randomly assigned to the exercise group and are using AQ to measure their efforts.
One-year follow-up with Mia Health
Participants are motivated by AQ, fitness age, and digital communication with the researchers.
Studying a wide range of health effects
NEXAF is investigating the effects of exercise on quality of life, disease burden, physical fitness, health risks, and changes in the heart.
The NEXAF Trial—the Norwegian EXercise and Atrial Fibrillation Trial—aims to lay the groundwork for specific exercise recommendations for people with atrial fibrillation. More than 33 million people worldwide have atrial fibrillation, making it by far the most common heart rhythm disorder.
NEXAF seeks to provide definitive answers on how exercise affects symptoms and the burden of disease associated with atrial fibrillation. The study may also reveal what changes occur in the hearts of this patient group after a prolonged period of regular exercise.
Research institution
Publications
The NEXAF Trial Protocol
500 patients with atrial fibrillation are randomly assigned to digital follow-up with Mia Health or standard healthcare follow-up.